Dystrophin antibody (AA 3066-3321)
Quick Overview for Dystrophin antibody (AA 3066-3321) (ABIN7569084)
Target
See all Dystrophin (DMD) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 3066-3321
 - 
                                            
Purpose
 - Anti-DMD Polyclonal antibody
 - 
                                            
Purification
 - Antigen affinity purification.
 - 
                                            
Immunogen
 - E. coli - derived recombinant Human DMD (Ser3066-Ile3321).
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Buffer
 - 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
 - 
                                            
Preservative
 - ProClin
 - 
                                            
Precaution of Use
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Storage
 - 4 °C,-20 °C,-80 °C
 - 
                                            
Storage Comment
 - Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
 
 - 
                                            
 - 
    
- Dystrophin (DMD)
 - 
                                            
Alternative Name
 - DMD
 - 
                                            
Background
 - DMD,Dystrophin,
 - 
                                            
UniProt
 - P11532
 - 
                                            
Pathways
 - Skeletal Muscle Fiber Development
 
Target
 -